What Is Rifapentine
Rifapentine API is an antibiotic with antimycobacterial activity, belonging to the class of rifamycin derivatives and antimycobacterial drugs. It is mainly used to treat tuberculosis (TB). It can be used to treat new and recurrent TB. Bacteria need to synthesise RNA to produce proteins necessary for their growth, reproduction, and survival. By blocking this process, it can successfully stop bacteria from reproducing and eventually cause mycobacterial cells to die. Usually, it is a component of a combination treatment. This is because combination therapy helps prevent the formation of drug-resistant types of TB germs, which are hard to eradicate. If you are interested in rifapentine, please do not hesitate to contact Xi'an Sonwu
What Is Rifapentine Used For
1. Treatment of Active Tuberculosis (TB)
Rifapentine is used in combination with other anti-TB drugs (like isoniazid, pyrazinamide, and ethambutol) for active, drug-susceptible pulmonary TB.
It's a key component in specific shorter-course regimens. For example, the research team stated a 4-month daily regimen for confident adults and adolescents with uncomplicated, drug-susceptible pulmonary TB. This regimen is non-inferior to the standard 6-month regimen for appropriate patients.
After an initial intense daily phase, it is also used (in combination with isoniazid) in several once-weekly continuation phase regimens.
2. Treatment for Latent Tuberculosis Infection (LTBI)
This is one of its most essential and widely used applications. The drug enables a far shorter and more convenient course of treatment
than previous options.
3. Infections
caused by nontuberculous mycobacteria (NTM)
For nontuberculous mycobacterial infections, such as
Mycobacterium avium complex (MAC) is sometimes used as part of a combination therapy. It often results in lung infections in patients with chronic lung illness or weakened immune systems (e.g., HIV/AIDS).
Another mycobacterium that can cause lung disease akin to tuberculosis is Mycobacterium kansasii.
The specific NTM species and the outcomes of susceptibility testing
determine its success.
4. Hansen's
illness, or leprosy
Clofazimine and dapsone are two medications that can be used as part of a multidrug treatment (MDT) regimen to treat leprosy, a disease caused by the bacterium Mycobacterium leprae. Although it reduces transmission and helps eradicate the bacterium, not all guidelines identify it as a first-line medication.
5. Staphylococcal infections (rare)
Because the drug is active against Gram-positive bacteria (such as Staphylococcus aureus), it is sometimes used in conjunction with other antibiotics to treat severe or resistant Staphylococcal infections, including osteomyelitis (a bone infection) or infections linked to prostheses.
- It works by inhibiting bacterial RNA polymerase, disrupting protein synthesis - a mechanism that is effective against mycobacteria and some Gram-positive bacteria. Combination therapy is often necessary to prevent resistance and enhance efficacy.
What Is The Target Of Rifapentine
Rifapentine targets bacterial DNA-dependent RNA polymerase, specifically inhibiting this essential enzyme. Here's a detailed breakdown of its mechanism and implications
1. Molecular Target
Bacterial RNA Polymerase
It binds to the β-subunit of the bacterial RNA polymerase enzyme (encoded by the rpoB gene). This binding occurs near the enzyme's active site, physically blocking the elongation of messenger RNA (mRNA) during the transcription process.
Specificity
It selectively inhibits bacterial RNA polymerase without significantly affecting human (eukaryotic) RNA polymerase, making it a targeted antibiotic.
2. Consequences of Inhibition
Bactericidal Effect
By halting RNA synthesis, the drug prevents the production of essential proteins and enzymes required for bacterial survival, leading to rapid cell death.
Broad Activity
Effective against Mycobacterium tuberculosis (including dormant bacilli), M. leprae, and some Gram-positive bacteria. Less effective against most Gram-negative bacteria due to outer membrane permeability barriers.
3. Resistance Concerns
Mutations in the rpoB gene (especially in the "rifampin resistance-determining region") alter the drug-binding site, reducing its affinity.
Cross-resistance: the drug shares resistance mechanisms with other rifamycins (e.g., Rifampin). Monotherapy is avoided to prevent the emergence of resistance.
4. Clinical Relevance
Tuberculosis (TB)
Used for
Latent TB infection: 12-week once-weekly regimen (with isoniazid).
Active TB Part of combination therapy (e.g., with isoniazid, pyrazinamide).
What Is The Difference Between Rifapentine And Rifampin
Similarities
Both are rifamycin antibiotics.
Mechanism of action: Inhibits bacterial RNA polymerase (same molecular target).
Drug spectrum: Mainly used against Mycobacterium tuberculosis (active/latent tuberculosis) and some Gram-positive bacteria.
Drug resistance: Common rpoB gene mutations can lead to cross-resistance (if resistant to one, it may be resistant to both).
Side effects: Hepatotoxicity (liver damage),
Orange coloration of body fluids,
Drug interactions caused by CYP450 enzymes.
Main differences:
Both Rifapentine and rifampicin are rifamycin antibiotics, but there are significant differences in pharmacokinetics and clinical applications.
Long half-life: This product (13-17 hours) maintains effective concentrations longer after a single dose than rifampicin (3-5 hours).
Simplified medication: This drug only needs to be taken 1-2 times a week, whereas rifampicin must be taken daily, which significantly reduces the risk of missed doses, especially for patients in remote areas or those with poor compliance.
Clinical advantages: This drug is more effective and safer
Latent tuberculosis infection: The 12-week short-term regimen of this drug combination (administered once a week) is as effective as the long-term regimen of rifampicin, but patients are more accepting of it.
Prevention and treatment of drug resistance: This drug exhibits potent antibacterial activity and prolonged action, thereby reducing fluctuations in blood drug concentrations and minimizing the risk of drug resistance.
Risk of liver damage: Both may affect liver function, but under the condition of equal efficacy, this drug is used less frequently and has less interference with liver function.
Key clinical significance
1. Not interchangeable - this drug has a longer half-life and can be given weekly (for example, a 12-dose regimen for latent tuberculosis treatment). It's more substantial. CYP induction effect increases the risk of drug interactions (for example, interactions with HIV drugs and contraceptives).
2. Risk of drug resistance - For rifampicin-resistant tuberculosis, never use the two drugs interchangeably (cross-resistance will almost certainly occur).
When to choose which drug?
- Rifapentine
- First-line drug for latent TB (shorter course of treatment, 3 months, once a week, with better compliance).
- Treatment of selected cases of active TB under the guidance of a specialist.
- Rifampicin
- First-line drug for active TB (daily treatment).
- Non-TB infections (e.g., prosthetic joint infections, brucellosis).
If you would like to know the rifapentine API price, are interested in Xi'an Sonwu, or have other questions about the product, please do not hesitate to contact Xi'an Sonwu.
Email：sales@sonwu.com